insights_auto
Why is M1RN34 up 2,92%?
Dive Deeperchevron_right
M1RN34:BVMF
Moderna Inc Bdr
48,01 R$
arrow_upward
+2,92%(+1,36) 1D
7 қаз., 14:57:46 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for M1RN34...
Open
45,99 R$
High
48,50 R$
Low
45,65 R$
Mkt. cap
76,75 млрд
Avg. vol.
114,33 м.
Volume
78,00 мың
52-wk high
54,38 R$
52-wk low
6,02 R$
Shares outstanding
399,24 млн
No. of employees
5 мың
Open
45,99 R$
High
48,50 R$
Low
45,65 R$
Mkt. cap
76,75 млрд
Avg. vol.
114,33 м.
Volume
78,00 мың
52-wk high
54,38 R$
52-wk low
6,02 R$
Shares outstanding
399,24 млн
No. of employees
5 мың
News stories
From web sources and news partners
MarketBeat
·
21 минут бұрын
Moderna, Inc. $MRNA Shares Sold by Lake Hills Wealth Management LLC
Traders Union
·
3 сағат бұрын
Moderna stock resistance test at $197.74: Key levels to watch
Investing.com Canada
·
5 сағат бұрын
Tempus expands collaboration with Merck and Moderna on therapy By Investing.com
Investor's Business Daily
·
21 сағат бұрын
Biotechs Sell Off — These Are The Biggest Losers
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc Bdr